Page 16 - குவாங்டாங் மருந்து பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Date Time Share HKUMed discovers a novel mediator of liver fibrosis and its underlying mechanism that can be a new therapeutic target HKUMed discovers a novel mediator of liver fibrosis and its underlying mechanism that can be a new therapeutic target. The research was led by Dr Ruby Hoo Lai-chong (second from left), Assistant Professor, Department of Pharmacology and Pharmacy, HKUMed and Co-investigator of State Key Laboratory of Pharmaceutical Biotechnology, HKU. Dr Wu Xiaoping (second from right), post-doctoral fellow, Department of Pharmacology and Pharmacy, HKUMed is the first author. Other research team members include: Ms Zong Jiuyu (left) and Ms Zhang Zixuan (right), postgraduate student, Department of Pharmacology and Pharmacy, HKUMed.

United statesHong kongLi jingjingZong jiuyuZhang zixuanWang cunchuanRuby hoo lai chongShu linglingWu xiaopingHealth bureauKey laboratory of pharmaceutical biotechnologyUniversity of hong kong hkumedResearch grants councilDepartment of medicineTechnology programCollaborative research fund